Geetha Subramaniam

Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial

Joshua D. Lee, Edward V. Nunes, Patricia Novo et al. · The Lancet · 2017 · 699 citations · Full text

Nursing, Pharmacotherapy, Pain Management +15

Extended vs Short-term Buprenorphine-Naloxone for Treatment of Opioid-Addicted Youth

George Woody, Sabrina Poole, Geetha Subramaniam et al. · JAMA · 2008 · 358 citations · Full text

Education, Counseling, Pharmacotherapy +13

Performance of the Tobacco, Alcohol, Prescription Medication, and Other Substance Use (TAPS) Tool for Substance Use Screening in Primary Care Patients

Jennifer McNeely, Li‐Tzy Wu, Geetha Subramaniam et al. · Annals of Internal Medicine · 2016 · 312 citations · Full text

Nursing, Psychiatry, Behavioral Health +13

Prevalence, patterns, and correlates of multiple substance use disorders among adult primary care patients

William S. John, He Zhu, Paolo Mannelli et al. · Drug and Alcohol Dependence · 2018 · 131 citations

Nursing, Psychiatry, Primary Care +13

Randomized Controlled Trial of Osmotic-Release Methylphenidate With Cognitive-Behavioral Therapy in Adolescents With Attention-Deficit/Hyperactivity Disorder and Substance Use Disorders

Paula Riggs, Theresa Winhusen, Robert D. M. Davies et al. · Journal of the American Academy of Child & Adolescent Psychiatry · 2011 · 126 citations

Medicine, Pharmacotherapy, Psychiatry +17